Literature DB >> 6771072

Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement.

N Matthews, J M Stark, P S Harper, J Doran, D M Jones.   

Abstract

A patient is described who had a functional deficiency of the C8 complement component. His serum contained abnormal C8 which lacked some of the antigenic determinants of normal C8. The defect was associated with recurrent meningococcal infections due at different times to at least two strains. The patient's serum contained antibodies to meningococci and could induce phagocytosis and intracellular killing of the cocci by polymorphs. However, the serum was bactericidal only after the addition of C8-containing serum. As the patient did not give a history of susceptibility to other pyogenic organisms and has normal polymorph function, the circumstances of meningococcal infection must be unusual in that the plasma bactericidal activity critically determines the outcome: it may be that if large numbers of meningococci are not killed in the plasma, the polymorphs are overwhelmed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771072      PMCID: PMC1537948     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

Review 1.  Chronic granulomatous disease.

Authors:  R B Johnston; S L Newman
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

2.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

3.  Lymphocyte-associated complement: role of C8 in certain cell-mediated lytic reactions.

Authors:  P Perlmann; H Perlmann; P Lachmann
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

5.  Complete absence of the third component of complement in man.

Authors:  M Ballow; J E Shira; L Harden; S Y Yang; N K Day
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Bactericidal and opsonic activity against Neisseria gonorrhoeae in sera from patients with disseminated gonococcal infection.

Authors:  G F Brooks; K S Israel; B H Petersen
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

7.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.

Authors:  D Lim; A Gewurz; T F Lint; M Ghaze; B Sepheri; H Gewurz
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

9.  A second case of human C3b inhibitor (KAF) deficiency.

Authors:  R A Thompson; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

10.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  7 in total

1.  Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.

Authors:  K T Mountzouros; A P Howell
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Authors:  Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

4.  Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).

Authors:  C A Alper; D Marcus; D Raum; B H Petersen; T J Spira
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

5.  Inherited C8 beta subunit deficiency in a patient with recurrent meningococcal infections: in vivo functional kinetic analysis of C8.

Authors:  C P Rao; J O Minta; B Laski; C A Alper; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system.

Authors:  P Densen; E J Brown; G J O'Neill; F Tedesco; R A Clark; M M Frank; D Webb; J Myers
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

7.  SLE like syndrome and functional deficiency of C1q in members of a large family.

Authors:  A J Hannema; J C Kluin-Nelemans; C E Hack; A J Eerenberg-Belmer; C Mallée; H P van Helden
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.